Descovy
My Prescription
Payment
Select pharmacy
$2,265.04
Print or send this coupon to your phone
AlbertsonsPowered byAbout Descovy
Drug Details
Descovy, a combination of emtricitabine and tenofovir alafenamide, is an antiretroviral medication used in the management of HIV infection in both adults and children, as well as for HIV prevention in individuals at high risk (known as PrEP). This medication works by inhibiting the replication of HIV, helping to reduce the amount of the virus in the body, which in turn supports the immune system's function and decreases the likelihood of HIV-related complications such as infections and certain cancers. However, it is important to note that Descovy should not be used alone for HIV treatment; it must be part of a combination regimen with other HIV medications. For prevention, Descovy is effective except for receptive vaginal sex. Common side effects include nausea and diarrhea. While Descovy is not a cure for HIV, it plays a critical role in controlling the infection and reducing the risk of transmission. Always follow your healthcare provider's instructions, use recommended protective measures during sexual activity, and do not share personal items that could transmit the virus.
Price history for Descovy
30 Tablets, 200-25MG
Average retail price for Descovy
Average SaveHealth price for Descovy
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Descovy dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 120-15MG | 30 Tablets | $2,262.62 | $75.42 |
| 200-25MG | 30 Tablets | $2,265.24 | $75.51 |
Descovy FAQs
Descovy is a medication used for the treatment and prevention of HIV-1 infection. It is typically prescribed as part of a combination antiretroviral therapy for individuals living with HIV. Additionally, Descovy is used for pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV-1 in certain high-risk populations.
Descovy is not recommended for use as pre-exposure prophylaxis (PrEP) in individuals at risk of HIV from receptive vaginal sex because its effectiveness in this population has not been established. Clinical trials primarily focused on men who have sex with men and transgender women, and there is insufficient data on its efficacy for cisgender women. However, Descovy is approved for treatment of HIV-1 infection in combination with other antiretroviral agents for both males and females.
Descovy is primarily used for HIV treatment and pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection. It may also be used off-label for other conditions as determined by a healthcare provider, but these uses should be discussed with a medical professional.
Descovy is a medication used for HIV treatment and prevention. It is typically prescribed for:1. **HIV Treatment**: Adults and children weighing at least 25 kg who are HIV-positive, as part of a combination antiretroviral therapy.2. **HIV Pre-exposure Prophylaxis (PrEP)**: Adults and adolescents weighing at least 35 kg who are at risk of HIV-1 infection through sexual activity, excluding those at risk from receptive vaginal sex.Eligibility for Descovy should be determined by a healthcare provider, considering individual health conditions and risk factors.
Descovy is not exclusively for males. It is approved for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection in certain populations, including men and transgender women who have sex with men. However, it is not approved for use in individuals at risk from receptive vaginal sex, which is why it may seem like it is only for males. This limitation is due to the lack of sufficient clinical trial data in cisgender women.